Rabies can be effectively prevented through vaccination, yet is still one of the most devastating diseases. A European project has identified a number of compounds that can prolong survivorship after rabies infection.
Rabies encephalitis is 100 % fatal disease. Pathogenesis of the disease is poorly understood and this limits possibilities to design rational intervention strategies. The main goal of the EU-funded ASKLEPIOS (Advanced studies towards knowledge on lyssavirus encephalitis pathogenesis improving options for survival) project was to find antiviral molecules to treat patients who have already developed clinical disease associated with rabies virus infection.
Further details: Effective treatment of rabies infection